Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
Wenyu Ye1, Haya Ascher-Svanum2, Jennifer A Flynn3, Yuka Tanji3, Michihiro Takahashi3,41Lilly Suzhou Pharmaceutical Co, Shanghai, People's Republic of China; 2Eli Lilly and Company, Indianapolis, IN, USA; 3Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Kobe, 4Terauchi-Takahashi Psyc...
Saved in:
Main Authors: | Ye W (Author), Ascher-Svanum H (Author), Flynn JA (Author), Tanji Y (Author), Takahashi M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
by: Xiaomei Peng, et al.
Published: (2011) -
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
by: Montgomery W, et al.
Published: (2013) -
The incidence of dysrhythmias after administration of the antipsychotic olanzapine
by: Gulač P., et al.
Published: (2016) -
Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study
by: Cristiana Montemagni, et al.
Published: (2022) -
Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
by: Jiahong Liu, et al.
Published: (2021)